Jason M. Allen was almost too nervous to enter his first art competition. Now, his award-winning image is sparking controversy about whether art can be generated by a computer, and what, exactly ...

It has been about a month since the last earnings report for Nevro (NVRO). Shares have added about 0.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

Nevro (NVRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

It has been about a month since the last earnings report for Nevro (NVRO). Shares have added about 0.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

The sculpture is part of The Line, London’s first dedicated public art walk, and is formed of slender steel tubes painted black, red and green in Rothschild’s autograph stripe motif. The artist – who ...

Nevro. Corp. closed the acquisition of privately held Vyrsa Technologies Inc., adding the company’s V1 implant for sacroiliac (SI) joint fusion to its product line for chronic pain. Nevro paid $40 ...

Reports Q3 revenue $96.9M, consensus $93.07M. "Our worldwide revenue and adjusted EBITDA came in better than we anticipated in the third quarter of 2024. In addition, our cash position reflects ...

Nevro Corp. shares have significantly underperformed, selling 57% lower than in 2021. The company's top-line momentum continues, but it faces economic challenges and lacks value creation for ...

Citi has upgraded Nevro (NYSE:NVRO) to neutral, citing the recent sell-off in shares following the company’s revised guidance. The investment bank noted that Nevro shares have fallen around 74% ...

Nevro is a medical device company that focuses on therapies to treat chronic pain. The company's earnings didn't keep up with company guidance or analysts' expectations, and Nevro also lowered ...